Peptides for inflammation: what a clinician can actually prescribe in 2026
Search “peptides for inflammation” and you will mostly find BPC-157 and TB-500. As of October 2026, neither can be legally compounded by a licensed U.S. pharmacy, so neither can be prescribed in the ordinary way. Products sold online as “research use only” are unapproved drugs; we do not sell or link to them.
Where the popular peptides stand
- BPC-157: placed by FDA in 2023 among bulk substances that raise significant safety concerns, which blocks compounding. An FDA advisory panel recommended in July 2026 that it be allowed; FDA has not acted.
- TB-500 (thymosin beta-4 fragment): also on FDA’s safety-concern list for compounding.
- Status can change. We update our BPC-157 guide the day it does.
What a clinician can prescribe
- Glutathione and NAD+ are commonly compounded and used in some recovery protocols. They are not FDA-approved and human evidence for the injectable forms is limited.
- Conventional anti-inflammatory and pain treatments remain the evidence-backed options for many conditions and are worth discussing honestly with a clinician.
The foundations that matter more
For most people with low-grade inflammation, the strongest evidence sits with unglamorous things: weight loss if indicated, sleep, regular movement, a diet built around vegetables, legumes, fish, and olive oil, omega-3 intake, limiting alcohol, and managing blood sugar. An ND will usually build this base before considering any injectable.
Safety information
Compounded peptides are not FDA-approved and have not been evaluated by FDA for safety, effectiveness, or quality. Only a licensed clinician can decide whether one is appropriate for you.
Sources
- ajmc.com/view/fda-panel-backs-6-peptides-for-compounding
- fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks
Read next
-
Is BPC-157 legal in the U.S.? Status as of October 2026
BPC-157 is not available by prescription, FDA sent warning letters to online sellers in August 2026, and an advisory panel has recommended a change. Here is where it stands.
-
Sermorelin vs ipamorelin: which is legal to prescribe, and what is the difference?
Both nudge your body to release growth hormone, but only one is commonly available through licensed compounding pharmacies today. Here is how they compare.